162 related articles for article (PubMed ID: 16330939)
1. Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2006 Jan; 30(1):28-35. PubMed ID: 16330939
[TBL] [Abstract][Full Text] [Related]
2. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
[TBL] [Abstract][Full Text] [Related]
3. Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.
Shia J; McManus M; Guillem JG; Leibold T; Zhou Q; Tang LH; Riedel ER; Weiser MR; Paty PB; Temple LK; Nash G; Kolosov K; Minsky BD; Wong WD; Klimstra DS
Am J Surg Pathol; 2011 Jan; 35(1):127-34. PubMed ID: 21164296
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiotherapy alters the expression and prognostic significance of adhesion molecules in Barrett's-associated adenocarcinoma.
Turner JR; Torres CM; Wang HH; Shahsafaei A; Richards WG; Sugarbaker D; Odze RD
Hum Pathol; 2000 Mar; 31(3):347-53. PubMed ID: 10746678
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy.
Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
Am J Surg Pathol; 2013 Jan; 37(1):47-52. PubMed ID: 23060350
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
[TBL] [Abstract][Full Text] [Related]
7. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
[TBL] [Abstract][Full Text] [Related]
8. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
Raouf AA; Evoy DA; Carton E; Mulligan E; Griffin MM; Reynolds JV
Dis Esophagus; 2003; 16(1):17-23. PubMed ID: 12581249
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
[TBL] [Abstract][Full Text] [Related]
10. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases.
Paraf F; Fléjou JF; Pignon JP; Fékété F; Potet F
Am J Surg Pathol; 1995 Feb; 19(2):183-91. PubMed ID: 7832278
[TBL] [Abstract][Full Text] [Related]
11. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
12. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus.
Collard JM; Romagnoli R; Hermans BP; Malaise J
Am J Surg; 1997 Sep; 174(3):307-11. PubMed ID: 9324143
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD; Buckles D; Al-Kasspooles M
Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
[TBL] [Abstract][Full Text] [Related]
14. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of adenocarcinoma arising in Barrett's esophagus.
Hoff SJ; Sawyers JL; Blanke CD; Choy H; Stewart JR
Ann Thorac Surg; 1998 Jan; 65(1):176-80; discussion 180-1. PubMed ID: 9456113
[TBL] [Abstract][Full Text] [Related]
16. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
Heitmiller RF; Redmond M; Hamilton SR
Ann Surg; 1996 Jul; 224(1):66-71. PubMed ID: 8678620
[TBL] [Abstract][Full Text] [Related]
17. Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study.
Szachnowicz S; Cecconello I; Ribeiro U; Iriya K; El Ibrahim R; Takeda FR; Corbett CE; Vaz Safatle-Ribeiro A
World J Surg Oncol; 2009 Mar; 7():27. PubMed ID: 19272137
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
[TBL] [Abstract][Full Text] [Related]
19. Limited resection for early adenocarcinoma in Barrett's esophagus.
Stein HJ; Feith M; Mueller J; Werner M; Siewert JR
Ann Surg; 2000 Dec; 232(6):733-42. PubMed ID: 11088068
[TBL] [Abstract][Full Text] [Related]
20. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]